BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31686319)

  • 1. Genome-editing technologies: the gap between application and policy.
    Li G; Liu YG; Chen Y
    Sci China Life Sci; 2019 Nov; 62(11):1534-1538. PubMed ID: 31686319
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on the Application of Genome-Editing Technologies in Crop Breeding.
    Hua K; Zhang J; Botella JR; Ma C; Kong F; Liu B; Zhu JK
    Mol Plant; 2019 Aug; 12(8):1047-1059. PubMed ID: 31260812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revolutionize Genetic Studies and Crop Improvement with High-Throughput and Genome-Scale CRISPR/Cas9 Gene Editing Technology.
    Yang N; Wang R; Zhao Y
    Mol Plant; 2017 Sep; 10(9):1141-1143. PubMed ID: 28803899
    [No Abstract]   [Full Text] [Related]  

  • 4. Clarifying the regulation of genome editing in Australia: situation for food.
    Kelly L
    Transgenic Res; 2019 Aug; 28(Suppl 2):161-164. PubMed ID: 31321699
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploitation of genetic resources based on regulome and gene editing in crops.
    Li Y; Yan W
    Sci China Life Sci; 2020 Sep; 63(9):1406-1409. PubMed ID: 32318908
    [No Abstract]   [Full Text] [Related]  

  • 6. Current and future editing reagent delivery systems for plant genome editing.
    Ran Y; Liang Z; Gao C
    Sci China Life Sci; 2017 May; 60(5):490-505. PubMed ID: 28527114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome Editing for Global Food Security.
    Ma X; Mau M; Sharbel TF
    Trends Biotechnol; 2018 Feb; 36(2):123-127. PubMed ID: 28893405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
    Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
    Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One Prime for All Editing.
    Yang L; Yang B; Chen J
    Cell; 2019 Dec; 179(7):1448-1450. PubMed ID: 31835025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Genetic Stock to Genome Editing: Gene Exploitation in Wheat.
    Wang M; Wang S; Liang Z; Shi W; Gao C; Xia G
    Trends Biotechnol; 2018 Feb; 36(2):160-172. PubMed ID: 29102241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 17. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome Editing and Hematologic Malignancy.
    Emmer BT; Ginsburg D
    Annu Rev Med; 2020 Jan; 71():71-83. PubMed ID: 31469969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing: Past, Present, and Future.
    Carroll D
    Yale J Biol Med; 2017 Dec; 90(4):653-659. PubMed ID: 29259529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.